Supplements for Seniors: What is Safe, What Helps, and What to Absolutely Avoid

After age 65, it's rarely just about deficiency. More often, it's about what the supplement will do with the medications you are already taking. In a representative study of Americans aged 62-85, the percentage of individuals taking five or more prescription medications increased over five years from 30.6% to 35.8%, while the percentage using dietary supplements rose from 51.8% to 63.7%. During the same period, the percentage of individuals exposed to serious drug interactions doubled, from 8.4% to 15.1% (Qato i wsp., JAMA Internal Medicine, 2016). Below you will find what can be supported by research: where supplementation in seniors has evidence, where it alters drug concentrations in the blood, and what data does not confirm, despite circulating in guides.

KEY INFORMATION
• The percentage of individuals aged 62-85 exposed to serious drug interactions increased from 8.4% to 15.1% over five years (Qato et al., JAMA Intern Med, 2016).
• St. John's Wort induces CYP3A4 and P-glycoprotein, thereby lowering the levels of warfarin, digoxin, and cyclosporine (Nicolussi et al., 2020).
• Polish guidelines from 2023 recommend 1000-2000 IU of vitamin D daily for ages 65-75 and 2000-4000 IU for those over 75.
• Vitamin E at doses of 400 IU daily is associated with an increase in overall mortality in a meta-analysis of 19 studies (Miller et al., 2005).

Why are interactions a greater risk for seniors than deficiencies?

Because supplements do not work in a vacuum. In the Qato et al. study from 2016, 35.8% of individuals aged 62-85 were taking at least five prescription medications, and 63.7% were using dietary supplements. The percentage exposed to serious drug interactions reached 15.1%.

A summary from the same study shows why this is not a theoretical problem. Over five years, the use of statins increased from 33.8% to 46.2%, antiplatelet drugs from 32.8% to 43.0%, and fish oil from 4.7% to 18.6%. These three preparations are increasingly found in the same drawer, and the first two have documented interactions with popular herbs.

Additionally, there is a change in pharmacokinetics. With age, glomerular filtration decreases, so substances excreted by the kidneys, including potassium and magnesium, remain in the body longer. A slower hepatic metabolism means that any inducer or inhibitor of liver enzymes has a greater effect. This is not an argument against supplementation, but rather for adding preparations one at a time.

We noticed while gathering materials that the method of the Qato study is instructive. Interviewers did not ask for a list from memory but looked at the packaging in the patient's home. During a doctor's visit, it works the same way: a bag of packages speaks more than the answer 'I take something for my heart and vitamins'.

Which supplements most often alter the effects of medications?

Six groups frequently appear in the literature regarding older adults: St. John's Wort, ginseng, potassium supplements, vitamin K, minerals that bind medications in the gastrointestinal tract, and omega-3 fatty acids. The table below compares the mechanism with a specific source.

Two conclusions can be drawn from the table. Some items work both ways: ginseng weakens warfarin, so the risk is thrombosis, not hemorrhage. With minerals, the issue is often not the substance itself, but the timing of intake.

Dlaczego dziurawiec jest osobnym problemem przy wielu lekach?

St. John's Wort is one of the strongest plant-based enzyme inducers described in humans. It activates the PXR receptor, which in turn increases the activity of cytochrome CYP3A4 and P-glycoprotein. The effect is counterintuitive: the drug does not work stronger, but weaker, because it disappears from the blood faster.

The scale of this phenomenon is known from hard cases. In 2000, the interaction of St. John's Wort with cyclosporine led to acute transplant rejection in two heart transplant patients (Nicolussi i wsp., British Journal of Pharmacology, 2020). The same review mentions altered pharmacokinetics of digoxin, tacrolimus, indinavir, warfarin, alprazolam, simvastatin, and oral contraceptives. A broader systematic review, covering 128 case reports and 80 clinical studies, adds atorvastatin, omeprazole, verapamil, and nifedipine to the list (Izzo i Ernst, Drugs, 2009).

There is still a catch that complicates assessing the risk on your own. The strength of CYP3A4 induction correlates with the content of hyperforin in the preparation, which varies between products. Two packages with the same plant name on the label may not work the same. You can find more about herb-drug interactions in the entry on undesirable combinations between herbs and drugs.

How do calcium and iron affect drug absorption?

They bind the drug in the intestine before it can be absorbed. In a study with 20 people with hypothyroidism, taking 1200 mg of elemental calcium in the form of carbonate together with levothyroxine for three months lowered the average concentrations of free and total thyroxine (Singh i wsp., JAMA, 2000).

Iron does the same, and more clearly. In 14 patients with hypothyroidism, simultaneous intake of 300 mg of iron sulfate with thyroxine for 12 weeks raised the average TSH from 1.6 to 5.4 mU/l, and in nine of them, symptoms of hypothyroidism worsened (Campbell i wsp., Annals of Internal Medicine, 1992).

Quinolone antibiotics have the same problem. A systematic review of 109 studies on 22 quinolones showed that all substances analyzed in this group lose bioavailability when taken together with antacids and mineral supplements. Milk reduced absorption in half of the studied quinolones, most significantly with ciprofloxacin, while calcium-fortified orange juice worsened the bioavailability of ciprofloxacin and levofloxacin (Wiesner i wsp., Clinical Pharmacokinetics, 2024). The time interval between the drug and the mineral is a variable that these studies modified, so for a specific interval, ask your pharmacist.

When do potassium and vitamin K require a conversation with a doctor?

Whenever there are antihypertensive medications or anticoagulant treatment in the background. Hyperkalemia, or potassium concentration in serum above 5.0 mmol/l, often has a drug-induced cause in everyday practice, and potassium-containing preparations are listed in reviews as a separate group of its causes.

The mechanism concerns medications that seniors often take for years. Inhibition of the renin-angiotensin-aldosterone axis limits potassium excretion by the kidneys, so ACE inhibitors, sartans, and aldosterone antagonists raise its concentration. Potassium-sparing diuretics, non-steroidal anti-inflammatory drugs, heparins, and trimethoprim do the same (Ben Salem i wsp., Drug Safety, 2014). Popular magnesium preparations with potassium hit the same spot, and potassium may be in fine print on the label.

The situation with vitamin K is different from what the common prohibition suggests. In a study of patients at a Dutch anticoagulation clinic, individuals with low usual intake of vitamin K had a higher risk of INR below the therapeutic range, and in this group, recent intake was twice as high among patients compared to the control group, 164 versus 85 µg daily. The authors conclude that a constant, sufficient intake stabilizes INR against random fluctuations (Rombouts i wsp., British Journal of Haematology, 2010). The problem is therefore the spike, and starting or stopping a K2 preparation is exactly such a spike.

What do Polish guidelines say about vitamin D after the age of 65?

They provide separate doses for two age groups. The 2023 guidelines recommend that individuals aged 65-75 take cholecalciferol at a dose of 1000-2000 IU daily throughout the year, and those over 75 years old 2000-4000 IU daily, in both cases considering body weight and dietary intake.

The justification is physiological. The skin of an older person synthesizes vitamin D less efficiently, and in the older age group, possible absorption disorders and altered metabolism add to this. The document also defines laboratory thresholds: a concentration of 25(OH)D below 20 ng/ml indicates deficiency, 20-30 ng/ml indicates suboptimal status, and 30-50 ng/ml indicates optimal value (Płudowski et al., Nutrients, 2023). Popularna w internecie granica 60 ng/ml nie pochodzi z tego konsensusu.

There is also a correction that is easy to forget. In obesity, defined in adults and seniors as BMI over 30, the document mentions a usually twice as high dose than in peers with normal body weight. This is an argument for measuring 25(OH)D instead of guessing. How to combine D3 with vitamin K2 is described separately in the entry on witaminie D3 i K2.

Why is vitamin B12 deficiency in seniors often drug-induced?

Because two very popular medications after the age of 65 impair its absorption. In the DPPOS study, low levels of B12 after five years were found in 4.3% of those taking metformin compared to 2.3% in the placebo group, and low and borderline results together were found in 19.1% versus 9.5%.

After thirteen years, the difference remained for low and borderline results, 20.3% versus 15.6%. Each year of metformin use increased the chances of deficiency by 13% (OR 1.13; 95% CI 1.06-1.20), and neuropathy was more common in individuals treated with metformin who had low B12 levels. The authors state directly that routine monitoring of B12 levels in patients on metformin deserves consideration (Aroda i wsp., Journal of Clinical Endocrinology and Metabolism, 2016).

The second group consists of drugs that inhibit gastric acid secretion. In an analysis of 25,956 individuals diagnosed with B12 deficiency and 184,199 individuals without it, taking proton pump inhibitors for at least two years was associated with an odds ratio of 1.65 (95% CI 1.58-1.73), while H2 receptor blockers had an odds ratio of 1.25 (Lam i wsp., JAMA, 2013). Deficiency symptoms can be nonspecific, which we elaborate on in the post about niedoborze B12.

Which supplements have data on efficacy for seniors?

The most data is available for vitamin D and vitamin B12, for the reasons described above. For omega-3 fatty acids, the evidence is mixed, and for collagen, it is narrow but specific. The rest of the popular geriatric preparations are based on observational data or narrative reviews, rather than large randomized studies.

The VITAL study included 25,871 individuals taking 1 g of omega-3 daily for a median of 5.3 years. The primary endpoint, which was the number of serious cardiovascular events, did not differ from placebo, hazard ratio 0.92 (95% CI 0.80-1.06). However, among secondary outcomes, the number of heart attacks was lower, hazard ratio 0.72 (95% CI 0.59-0.90), and the authors did not report an excess of bleeding (Manson i wsp., NEJM, 2019). We elaborated on this in the post about dawkowaniu omega-3.

Collagen has a meta-analysis of randomized studies in osteoarthritis. It showed an improvement in the overall score on the WOMAC scale and the stiffness subscale, while the pain and function subscales did not differ from placebo in a statistically significant way (García-Coronado i wsp., International Orthopaedics, 2019). This is a narrow result, so it should be treated as a promise of less stiffness rather than a substitute for pain treatment.

Do high doses of calcium burden the heart?

The data is conflicting, and that is a fair answer. A meta-analysis of 15 randomized studies showed that calcium at a dose of 500 mg per day, given without vitamin D, was associated with a higher risk of heart attack: a hazard ratio of 1.31 based on individual data and a relative risk of 1.27 based on aggregate data.

Ta praca (Bolland i wsp., BMJ, 2010) sparked a discussion that continues to this day. A later systematic review, including four randomized studies and 27 observational studies, found no difference in the number of cardiovascular events or mortality between groups taking calcium and placebo. The authors concluded that calcium intake within the upper acceptable limits, i.e., 2000-2500 mg per day, is not associated with cardiovascular risk in generally healthy adults (Chung i wsp., Annals of Internal Medicine, 2016). It is worth noting that the review was funded by the National Osteoporosis Foundation.

The practical difference between these results comes down to the sum. A risk signal appeared with the supplement given without vitamin D and disappeared when total intake was counted within normal limits. Two sensible conclusions are: count calcium from diet together with that from tablets, and if you have heart disease, discuss the dose with your doctor instead of adding it as a precaution.

What should you really avoid, and what is not confirmed by research?

Four warnings are backed by large randomized studies, while one very popular warning, as it turns out, is not. It is worth separating these two sets, as unfounded prohibitions undermine the credibility of those that are substantiated.

Vitamin E at a dose of 400 IU daily performs the worst. A meta-analysis of 19 studies involving 135,967 individuals showed an increase in total mortality by 39 deaths per 10,000 individuals (95% CI 3-74) and a dose-dependent relationship above 150 IU daily (Miller i wsp., Annals of Internal Medicine, 2005). In the SELECT study involving 35,533 men, the same dose was associated with a higher risk of prostate cancer, hazard ratio 1.17 (Klein i wsp., JAMA, 2011). Beta-carotene with vitamin A in smokers raised the risk of lung cancer to 1.28, leading to the CARET study being halted 21 months ahead of schedule (Omenn i wsp., NEJM, 1996). Collectively, in 47 studies with low risk of error, antioxidants increased mortality, relative risk 1.05 (Bjelakovic i wsp., JAMA, 2007). Ephedrine raises the chances of psychiatric symptoms and heart palpitations by 2.2 to 3.6 times when losing weight at a rate of 0.9 kg per month (Shekelle i wsp., JAMA, 2003).

And now for the prohibition that has not been confirmed. A meta-analysis of 18 randomized studies involving 1985 individuals found no significant effect of standardized Ginkgo biloba extract on platelet aggregation, fibrinogen levels, APTT, or prothrombin time, and the authors did not confirm an increased risk of bleeding (Kellermann i Kloft, Pharmacotherapy, 2011). There are case reports, so the doctor should be aware of the preparation, but the hard "never with anticoagulants" does not stem from the data.

How to conduct a medication review and what to check on the label?

Start with the packaging, not from memory. Bring everything you take at least once a week to your appointment, including over-the-counter preparations and herbs. Ask your doctor or pharmacist to check three things: potassium, vitamin K, and minerals that require a time gap from medication.

On the label, check the content per serving, not per capsule, as a serving can consist of two or three capsules. Also, check if potassium and vitamin K are present in the composition, even if they are not in the product name. We elaborated on how to distinguish a supplement from a drug and what to look for in the composition in the post about the difference between a supplement and a drug.

Instead of guessing, base your decision on the result. Below are studies justified by the works cited above.

Frequently Asked Questions

Which supplements have the best evidence for people over 65?

Vitamin D is the most well-documented, with Polish guidelines from 2023 providing age-dependent doses. For omega-3, the VITAL study involving 25,871 participants did not show a decrease in serious cardiovascular events, although fewer heart attacks were recorded. The rest requires confirmation of deficiency through testing.

Czy witamina K2 jest bezpieczna przy warfarynie lub acenokumarolu?

The problem is not vitamin K itself, but the change in its supply. In a study by the Dutch anticoagulation clinic, individuals with a low usual supply had more frequent INR readings below the therapeutic range. Starting or stopping a K2 supplement is such a change, so it requires consultation with the attending physician.

Does metformin lower vitamin B12 levels?

In the DPPOS study, low B12 levels after five years were found in 4.3% of individuals taking metformin compared to 2.3% in the placebo group. Each year of medication use increased the chances of deficiency (OR 1.13). The authors recommend considering routine B12 monitoring in patients treated with metformin.

How much vitamin D do Polish guidelines recommend for seniors?

The 2023 guidelines recommend for individuals aged 65-75 years a daily intake of 1000-2000 IU of cholecalciferol throughout the year, and for those over 75 years, 2000-4000 IU daily. They consider an optimal concentration of 25(OH)D to be 30-50 ng/ml, and a deficiency to be values below 20 ng/ml.

Do omega-3s increase the risk of bleeding?

In the VITAL study, 25,871 participants took 1 g of omega-3 daily for a median of 5.3 years, and the authors did not report excess bleeding or other serious adverse events. When undergoing anticoagulant treatment, it is still advisable to consult the dosage with a physician, as the study did not test high doses.

Does ginkgo biloba really increase the risk of bleeding?

A meta-analysis of 18 studies involving 1,985 individuals did not show a significant effect of standardized extract on platelet aggregation, fibrinogen concentration, APTT, or prothrombin time. The authors did not confirm an increased risk of bleeding. There are descriptions of individual cases, so the physician should be aware of the supplement.

Preparaty wymienione w artykule znajdziesz w kategorii supplements. Before adding anything to your list of medications, show it to your doctor or pharmacist.

This article is for informational and educational purposes and does not constitute medical advice. Before starting supplementation, consult your doctor, especially if you are taking medications regularly, are pregnant or breastfeeding, or have a chronic illness.

Author: Michał Waluk · Opublikowano: 2026-06-22 · Aktualizacja: 2026-08-08